cis-urocanic acid attenuates acute dextran sodium sulphate-induced intestinal inflammation

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Albert, Eric ^a   Walker, John ^a   Thiesen, Aducio ^a   Churchill, Thomas ^a   Madsen, Karen ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; DEXTRAN SULFATE; INTERLEUKIN 10; INTERLEUKIN 17; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; UROCANIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BODY WEIGHT; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; FECES ANALYSIS; HISTOPATHOLOGY; IN VITRO STUDY; LOW DRUG DOSE; MOUSE; NONHUMAN; ORGAN WEIGHT; PROTECTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; WEIGHT REDUCTION; ANIMAL; CHEMICALLY INDUCED DISORDER; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; MOUSE MUTANT; PHYSIOLOGY;

MURINAE; MUS;

ANIMALS; ANTIGEN-PRESENTING CELLS; COLITIS; DEXTRAN SULFATE; FLOW CYTOMETRY; INTERLEUKIN-10; MICE; MICE, KNOCKOUT; UROCANIC ACID;

EID: 78149443108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013676     Document Type: Article

References (40)

1. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-962.
2. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
3. Danese S, Sans M, Fiocchi C (2004) Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 3: 394-400.
4. Loftus EV, Jr. (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517.
5. Ponsonby AL, McMichael A, van der Mei I (2002) Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181-182: 71-78.
6. Sonnenberg A, McCarty DJ, Jacobsen SJ (1991) Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 100: 143-149.
7. Nerich V, Monnet E, Etienne A, Louafi S, Ramee C, et al. (2006) Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 12: 218-226.
8. Peyrin-Biroulet L, Oussalah A, Bigard MA (2009) Crohn's disease: the hot hypothesis. Med Hypotheses 73: 94-96.
9. Mora JR, Iwata M, von Andrian UH. (2008) Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol.
10. De Fabo EC, Noonan FP (1983) Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. J Exp Med 158: 84-98.
11. Gibbs NK, Tye J, Norval M (2008) Recent advances in urocanic acid photochemistry, photobiology and photoimmunology. Photochem Photobiol Sci 7: 655-667.
12. Prater MR, Blaylock BL, Holladay SD (2003) Molecular mechanisms of cis-urocanic acid and permethrin-induced alterations in cutaneous immunity. Photodermatol Photoimmunol Photomed 19: 287-294.
13. Beissert S, Mohammad T, Torri H, Lonati A, Yan Z, et al. (1997) Regulation of tumor antigen presentation by urocanic acid. J Immunol 159: 92-96.
14. Garssen J, Norval M, Crosby J, Dortant P, Van Loveren H (1999) The role of urocanic acid in UVB-induced suppression of immunity to Trichinella spiralis infection in the rat. Immunology 96: 298-306.
15. Hart PH, Jones CA, Jones KL, Watson CJ, Santucci I, et al. (1993) Cis-urocanic acid stimulates human peripheral blood monocyte prostaglandin E2 production and suppresses indirectly tumor necrosis factor-alpha levels. J Immunol 150: 4514-4523.
16. Viiri J, Jauhonen HM, Kauppinen A, Ryhanen T, Paimela T, et al. (2009) Cis-urocanic acid suppresses UV-B-induced interleukin-6 and -8 secretion and cytotoxicity in human corneal and conjunctival epithelial cells in vitro. Mol Vis 15: 1799-1805.
17. Kivisto K, Punnonen K, Toppari J, Leino L (1996) Urocanic acid suppresses the activation of human neutrophils in vitro. Inflammation 20: 451-459.
18. Holan V, Kuffova L, Zajicova A, Krulova M, Filipec M, et al. (1998) Urocanic acid enhances IL-10 production in activated CD4+ T cells. J Immunol 161: 3237-3241.
19. Shreedhar VK, Pride MW, Sun Y, Kripke ML, Strickland FM (1998) Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J Immunol 161: 1327-1335.
20. Schwarz A, Maeda A, Wild MK, Kernebeck K, Gross N, et al. (2004) Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J Immunol 172: 1036-1043.
21. Kaneko K, Smetana-Just U, Matsui M, Young AR, John S, et al. (2008) cis-Urocanic acid initiates gene transcription in primary human keratinocytes. J Immunol 181: 217-224.
22. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116: 1107-1114.
23. Xu S, Cao X (2010) Interleukin-17 and its expanding biological functions. Cell Mol Immunol 7: 164-174.
24. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, et al. (1994) Dextran sulfate sodium-induced colitis occurs in severe combined immunode-ficient mice. Gastroenterology 107: 1643-1652.
25. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, et al. (1994) Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 144: 997-1007.
26. Shea-Donohue T, Thomas K, Cody MJ, Aiping Z, Detolla LJ, et al. (2008) Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun 14: 117-124.
27. Buanne P, Di Carlo E, Caputi L, Brandolini L, Mosca M, et al. (2007) Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. J Leukoc Biol 82: 1239-1246.
28. Rinaldi M, Moroni P, Leino L, Laihia J, Paape MJ, et al. (2006) Effect of cis-urocanic acid on bovine neutrophil generation of reactive oxygen species. J Dairy Sci 89: 4188-4201.
29. Roark CL, Simonian PL, Fontenot AP, Born WK, O'Brien RL (2008) gammadelta T cells: an important source of IL-17. Curr Opin Immunol 20: 353-357.
30. Henry T, Kirimanjeswara GS, Ruby T, Jones JW, Peng K, et al. (2010) Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections. J Immunol 184: 3755-3767.
31. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
32. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, et al. (2009) Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
33. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y (2004) Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 110: 55-62.
34. O'Connor W Jr., Kamanaka M, Booth CJ, Town T, Nakae S, et al. (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10: 603-609.
35. Iwakura Y, Nakae S, Saijo S, Ishigame H (2008) The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 226: 57-79.
36. Freitas A, Alves-Filho JC, Victoni T, Secher T, Lemos HP, et al. (2009) IL-17 receptor signaling is required to control polymicrobial sepsis. J Immunol 182: 7846-7854.
37. Kapp JA, Kapp LM, McKenna KC, Lake JP (2004) gammadelta T-cell clones from intestinal intraepithelial lymphocytes inhibit development of CTL responses ex vivo. Immunology 111: 155-164.
38. Rhodes KA, Andrew EM, Newton DJ, Tramonti D, Carding SR (2008) A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury. Eur J Immunol 38: 2274-2283.
39. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
40. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, et al. (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98: 1010-1020.